tiprankstipranks
Ondine Biomedical’s Steriwave Debuts in Australia
Company Announcements

Ondine Biomedical’s Steriwave Debuts in Australia

Ondine Biomedical, Inc. (GB:OBI) has released an update.

Ondine Biomedical Inc. has announced that Mater Hospital in Sydney is the first in Australia to adopt its Steriwave technology, which aims to reduce hospital-acquired infections using light-activated antimicrobial treatment. A study presented at the Spine Society of Australia meeting showed Steriwave significantly decreases surgical site infections and offers substantial cost savings per patient. The company is at the forefront of developing non-antibiotic methods for pathogen decolonization, backed by global health guidelines.

For further insights into GB:OBI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskOndine Biomedical Shareholders Unanimously Back Resolutions
TipRanks UK Auto-Generated NewsdeskOndine Biomedical’s Steriwave Joins NHS Supply Chain
TipRanks UK Auto-Generated NewsdeskOndine Biomedical’s Revenue and Hospital Deployments Surge
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!